×

Get the Prostate Cancer Patient Guide as a digital download or free mailed copy.

Click here.

09/20/2022

Prostate Cancer in U.S. Hispanic Men

Hispanic Heritage Month runs from September 15 to October 15. Below, Dr. Scarlett Gomez, a professor of epidemiology and biostatistics at the University of California, San Francisco, and an expert on cancer disparities, describes how prostate cancer is affecting Hispanic/Latino men. Key Takeaways: Prostate cancer remains a significant burden for. Read More

09/15/2022

(Almost) One-Pot Sweet Potato, Tofu, and Spinach Curry

Plant-based diets, Meatless Monday, “Veganuary”…..there’s a lot of talk these days about the potential health benefits, as well as environmental benefits, of eating less meat. For example, a study of more than 200,000 men in the U.K. showing that men who were vegetarian, and men who ate fish (but no. Read More

09/15/2022

LuPSMA: The Specifics (Part 2)

A whole new form of treatment for metastatic castrate-resistant prostate cancer (mCRPC) is here:  PSMA-targeting therapy.  The first PSMA-targeting therapy approved in the U.S. – with more being tested now in clinical trials – is LuPSMA (177Lu-PSMA-617; Pluvicto®), previously discussed here. We asked medical oncologist and PCF-funded scientist Michael J.. Read More

09/15/2022

LuPSMA: A Whole New Class of Treatment for Prostate Cancer (Part 1)

PSMA is a molecule that sits on the surface of prostate cancer cells, and we can look right at it.  It can’t hide from us – even in bits of cancer no bigger than a grain of rice – because, thanks to research funded by PCF, newly-approved radioactive tracers that. Read More

09/14/2022

Wild Dunes Men’s Golf Association Charity Event Gains Momentum

Over the past 29 years, many generous supporters, large and small, have contributed to the Prostate Cancer Foundation’s efforts to fund life-saving prostate cancer research. One source of support has been steadily increasing over nearly a decade, becoming the largest single private fundraiser benefiting PCF: the Wild Dunes Men’s Golf. Read More

09/09/2022

Improving Erectile Function, Part 2: What You Can Do After Surgery

Men undergoing surgery for prostate cancer often fear its side effects, including losing the ability to have erections. PCF-funded investigator Dr. Ashutosh Tewari, chairman of urology at the Icahn School of Medicine at Mount Sinai Hospital, and team have reviewed the latest research on strategies to improve erectile function that. Read More

09/09/2022

Improving Erectile Function, Part 1: What You Can Do Before Surgery

If you’ve been diagnosed with localized prostate cancer and are considering having surgery (radical prostatectomy), you may be concerned about potential side effects, including loss of erectile function. About 40% of men lose some erectile function after surgery. This can have a major impact on quality of life for both. Read More

08/31/2022

More Evidence For Benefits of Radiation Therapy in Metastatic Prostate Cancer

In the U.S., between 2010-2019, nearly 7% of patients diagnosed with prostate cancer had metastatic disease at diagnosis. In 2022, this could translate into more than 18,000 people. Multiple treatment options exist, including combinations of standard androgen deprivation therapy (ADT), novel hormonal therapies, and docetaxel. Since 2019, radiation therapy (RT). Read More

08/31/2022

From the White House: A Proclamation on National Prostate Cancer Awareness Month, 2022

Repost from: https://www.whitehouse.gov/briefing-room/presidential-actions/2022/08/31/a-proclamation-on-national-prostate-cancer-awareness-month-2022/ During National Prostate Cancer Awareness Month, we recommit ourselves to taking on a cancer that will affect over 260,000 people in America this year alone.  It is for those we have lost, those who continue to fight, and those who will undergo this battle in the future that. Read More

08/24/2022

PACT Act Expands Health Care for Veterans

Earlier this month, President Biden signed into law S. 3373, “The Sergeant First Class Heath Robinson Honoring Our Promises to Address Comprehensive Toxics (PACT) Act of 2022.” Prostate Cancer Foundation President and CEO Dr. Charles J. Ryan had the privilege of representing PCF at the White House signing ceremony. The. Read More